Trial · NCT07887724
Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis
NCT07887724, Not applicable, Recruiting, DINA KEUMALA SARI
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis. Trials, record NCT07887724. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887724
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Channa Striata and Curcuma Domestica Supplementation in Patients With Active Pulmonary Tuberculosis
- NCT number
- NCT07887724
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 80 participants, estimated
- Lead sponsor
- DINA KEUMALA SARI
- Conditions
- Pulmonary Tuberculosis
- Interventions
- CHANA STRIATA AND CURCUMA, Maltodextrin (Placebo)
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Interleukin-6 Concentration | baseline and 4 weeks | Interleukin-6 (IL-6) concentration will be measured in \[serum/plasma\] using \[laboratory assay\] and reported in \[unit\]. |
| Primary | C-Reactive Protein Concentration | baseline and 4 weeks | C-reactive protein (CRP) concentration will be measured in \[serum/plasma\] using \[laboratory method\] and reported in \[unit\]. |
| Primary | Health-Related Quality of Life Measured Using the EuroQol Five-Dimension Five-Level Questionnaire (EQ-5D-5L) Index | baseline and 4 weeks | Health-related quality of life will be assessed using the EuroQol Five-Dimension Five-Level questionnaire (EQ-5D-5L). Responses will be converted into an index value using the Indonesian value set. Index values range from -0.865 to 1.000, with higher values indicating better health-related quality of life. |
| Primary | Body Weight | Baseline and week 4 | Body weight will be measured using a digital weighing scale and reported in kilograms (kg). |
| Secondary | Body Mass Index | Baseline and week 4 | Body mass index (BMI) will be calculated as body weight in kilograms divided by height in meters squared and reported in kg/m². Body weight will be measured using \[weighing instrument\], and height will be measured using \[height measurement instrument\]. |
| Secondary | Muscle Mass | Baseline and week 4 | Muscle mass will be measured using \[measurement device and method\] and reported in \[kg or %\]. |
| Secondary | Mid-Upper Arm Circumference | Baseline and week 4 | Mid-upper arm circumference will be measured using a non-stretchable measuring tape at the midpoint between the acromion and olecranon and reported in centimeters (cm). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07887724
GET https://conductscience.org/api/trials/v1/NCT07887724/registered